Cigna Group: Form 10-K for the period ended Dec 31, 2023
Filed with the SEC on Feb 29, 2024 and accepted by EDGAR at Feb 29, 2024, 19:48 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2023-01-01 to 2023-12-31 | $195.26bn | us-gaap:Revenues |
| Cost of revenue | 12 months2023-01-01 to 2023-12-31 | $133.80bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 12 months2023-01-01 to 2023-12-31 | $14.82bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2023-01-01 to 2023-12-31 | $8.54bn | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2023-01-01 to 2023-12-31 | $141.0m | us-gaap:IncomeTaxExpenseBenefit |
| Diluted EPS | 12 months2023-01-01 to 2023-12-31 | $17.39 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2023-01-01 to 2023-12-31 | $17.57 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2023-01-01 to 2023-12-31 | 296,882,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2023-01-01 to 2023-12-31 | $11.81bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 12 months2023-01-01 to 2023-12-31 | $1.45bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2023-01-01 to 2023-12-31 | $2.28bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-12-31 | $7.82bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-12-31 | $37.35bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-12-31 | $152.76bn | us-gaap:Assets |
| Current liabilities | At period end2023-12-31 | $48.72bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-12-31 | $106.41bn | us-gaap:Liabilities |
| Current portion of debt | At period end2023-12-31 | $2.77bn | us-gaap:DebtCurrent |
| Short-term borrowings | At period end2023-12-31 | $1.24bn | us-gaap:CommercialPaper |
| Shareholders' equity | At period end2023-12-31 | $46.22bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001739940-24-000005. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.